30 closest matches · ranked by relevance
Waterpipe Smoking
Primary: Comparing Cotinine Pre-to-post Change Between 2 Waterpipe Smoking Sessions: Heating Waterpipe Tobacco by (a) Charcoal vs (b) an Electric Head — 34.9; 26.4 ng/mL — p=0.115
Waterpipe Size
Primary: Waterpipe Evaluation Scale — 4.2; 4.4; 4.7 units on a scale
Tobacco-Related Carcinoma
Primary: Change in Exhaled Breath Carbon Monoxide (CO) — 80.1; 40.8; 62.5; 45.5 ppm
Smoking, Hookah · Waterpipe Smoking
Primary: Level of Smoke Inhalation Measured by Topography Device — 50.96; 77.79; 63.17; 51.60 Liters
Waterpipe Tobacco Smoking
Primary: Behavioral Intentions — 1.83; 1.72; 2.21 score on a scale
Reactions to Warnings · Hookah Smoking
Primary: Emotional Reactions to Ads — 2.81; 3.46; 3.74; 2.83 score on a scale
Waterpipe Tobacco Smoking
Primary: Willingness to Try Hookah Tobacco (Packaging Task ) — 1.9; 1.87; 1.9; 1.63 score on a scale
Waterpipe Tobacco Smoking
Primary: Change in Expired Carbon Monoxide (eCO Boost) — 25.7; 23.5 parts per million
Hookah Smoking
Primary: Perceived Harm — 4.1; 4.2; 4.5 score on a scale
Endothelial Dysfunction · Inflammation · Oxidative Stress
Primary: Flow-Mediated Dilation (FMD) — 6.11; 5.89; 4.79; 7.31 percentage of arterial diameter
Hookah Tobacco Smoking
Primary: Hookah Tobacco Initiation — 11; 5 Participants
Marijuana Dependence
Primary: Plasma THC — 6; 53; 70; 7 ng/mL
Smoking Behaviors
Primary: Number of Puffs Taken (Video-scored Smoking Behavior Outcome 1) — 15.8; 16.7; 19.1; 19.6 puffs
Marijuana Dependence
Primary: Mean Delivered and Retained Doses — 0.016; 0.018; 0.026 grams (g)
Smoking · Tobacco Use
Primary: Number of Participants Who Prefer IQOS — 7 Participants
Smoking · Heavy Episodic Drinking
Primary: Number of Participants With Reported 7-day Point Prevalence Abstinence at 3 Months — 3; 4 Participants
Tobacco Use Disorder
Primary: Product Preference — 27; 23; 24; 24 participants
Periodontal Diseases · Chronic Periodontitis · Periodontal Pocket
Primary: Periodontal Pocket Depth (PD) Change From Baseline at 6 Months — -1.046; -1.114; -1.177 millimeters — p=0.297
Nicotine Dependence
Primary: Toxicant Exposure by Products — 835.3; 782.1; 726.8; 0.157 ng/ml — p=0.002
Cannabis Use Disorder · Tobacco Use Disorder
Primary: Tobacco Quit Attempts — 13; 17 Participants — p== 0.33
Smoking Cessation
Primary: Self-reported 7-day Point Prevalence Abstinence — 26; 31 Participants
Smoking (Tobacco) Addiction
Primary: Puffing Topography: Puff Duration — 1.99; 2.06; 2.66; 1.87 seconds
Cigarette Smoking Toxicity
Primary: Smoking Topography- Puff Volume — 518; 661; 650; 620 mL
Cigarette Smoking · Smoking Behaviors
Primary: Puff Topography — 1108; 1045.2; 1084.6 mL
Healthy Volunteers
Primary: Nicotine Cmax — 13.00; 12.97; 6.00; 6.87 ng/mL
Tobacco Use
Primary: Summary of Urine Total NNAL Amount Excreted and Absolute Change From Baseline (ng/24 Hour) by Study Group and Study Day (mITT Population) — 511.889; 581.676; 548.751…
Positron Emission Tomography
Primary: PET Scan, Rating Scales — 7.1; 8.6; 7.9; 8.0 Vt/fp or mL/cm3
Tobacco Use
Primary: Baseline-adjusted Plasma Nicotine Concentration Pharmacokinetic (PK) Parameters [Cmax] Assessment — 6.426; 7.953; 8.288; 7.993 ng/mL
Smoking, Cigarette
Primary: Subjective Response to Smoking Cigarettes From the Cigarette Evaluation Scale — 4.68; 4.50 score on a scale — p=>.05
Tobacco Dependence · Schizophrenia
Primary: End-of-session Carbon Monoxide — 62.7; 43.0 parts per million (ppm)